Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases

Introduction: Childhood acute lymphoblastic leukemia (ALL) is a hematologic malignancy characterized by the acquisition of several genetic lesions in the lymphoid progenitors with subsequent proliferation advantage and lack of maturation. Along the years, it has been repeatedly shown that minimal re...

Descripción completa

Detalles Bibliográficos
Autores principales: Radu, Letitia-Elena, Colita, Andrei, Pasca, Sergiu, Tomuleasa, Ciprian, Popa, Codruta, Serban, Catalin, Gheorghe, Anca, Serbanica, Andreea, Jercan, Cristina, Marcu, Andra, Bica, Ana, Teodorescu, Patric, Constantinescu, Catalin, Petrushev, Bobe, Asan, Minodora, Jardan, Cerasela, Dragomir, Mihaela, Tanase, Alina, Colita, Anca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338564/
https://www.ncbi.nlm.nih.gov/pubmed/32695667
http://dx.doi.org/10.3389/fonc.2020.00923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338564/
https://www.ncbi.nlm.nih.gov/pubmed/32695667
http://dx.doi.org/10.3389/fonc.2020.00923

Ejemplares similares